CEBIOTEX SL
A Healthtech startup included in the Barcelona & Catalonia Startup Hub

CEBIOTEX
Cebiotex is an innovative clinical stage biotechnology start-up with the current mission to provide solutions to patients with cancer, both adult and paediatric through its CEBIOTEX Technological Platform patented at international level. First drug, CEB-01, in Ph1/2, is the first pharmaceutical product for Soft Tissue Sarcomas (STS) local control after tumour removal that covers an unmet oncological need by helping surgeons to obtain optimal results in their surgical interventions.
Industries & Technologies
Financial data
Other information
Funding
0.7M € (September 2018)
Minority stake unknown %
Investors: UNDISCLOSED PRIVATE INVESTORS
1.8M € (February 2017)
Minority stake unknown
Investors: SHIP2B, INVEREADY, UNDISCLOSED FAMILY OFFICES, CAPITAL CELL, CDTI, ENISA, EUROPEAN COMISSION
0.3M € (May 2016)
Minority stake 10.71%
Investors: CROWD-FUNDING INVESTORS
0.3M € (June 2015)
Minority stake unknown %
Investors: ESADEBAN AND OTHER PRIVATE INVESTORS THROUGH CAPITALLCELL
Source: Press releases newsletters & platforms company websites annual reports & accounts regulatory body sites & stock exchanges
@cebiotex
Other startups near startup CEBIOTEX
similar companies
Collaborators of Barcelona & Catalonia Startup Hub.
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.